Om

NanoSphere Health Sciences Inc. is a nano-biotechnology company specializing in advanced delivery systems for biologically active compounds. The firm’s primary focus is on its patented NanoSphere Delivery System, a platform that uses nanotechnology to improve the bioavailability and absorption of cannabinoids, pharmaceuticals, nutrients, supplements, nutraceuticals, and over-the-counter medications. By encapsulating active ingredients into phospholipid-based nanoparticles, NanoSphere Health Sciences Inc. aims to provide non-invasive, user-friendly administration routes that can enhance onset, consistency, and efficacy of these compounds in human and animal health applications. The company operates through licensing and joint venture arrangements, allowing partners in the cannabis, pharmaceutical, wellness, and animal health sectors to integrate its delivery technology into their own product portfolios. Headquartered in Vancouver, Canada and founded in 2005, NanoSphere Health Sciences Inc. today positions itself within the broader healthcare and biotechnology ecosystem as a technology provider focused on next-generation drug and nutrient delivery solutions.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I NANOSPHERE HEALTH SCIENCES MED ENDAVU: Køb NanoSphere Health Sciences ($NSHS.X) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i NanoSphere Health Sciences, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.